Drug Trial Radar · NCT03732638
Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults
Last checked: Nov 20, 2026Latest source record: Jun 7, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,590
Actual
Start
Nov 14, 2018
Primary completion
Dec 10, 2019
Study completion Feb 2, 2021
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Nov 6, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.
Conditions
- Migraine
Interventions
RimegepantDrug
Rimegepant 75 mg tablet EOD
PlaceboDrug
Placebo tablet to match rimegepant tablet EOD
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in the Mean Number of Total Migraine Days Per Month in the Last 4 Weeks of the DBT PhaseTime frame: OP and Weeks 9 to 12 of the DBT phase
Locations
93 sites in 1 country. Site status is shown where the registry gives one.
MDFirst Research-Chandler
Chandler, Arizona
MedPharmics, LLC
Phoenix, Arizona
Tucson Neuroscience Research
Tucson, Arizona
Baptist Health Center for Clinical Research
Little Rock, Arkansas
Anaheim Clinical Trials
Anaheim, California
Axiom Research, LLC
Apple Valley, California
Axiom Research, LLC
Colton, California
eStudySite
La Mesa, California
Synergy San Diego
Lemon Grove, California
Collaborative Neuroscience Network, LLC
Long Beach, California
Pacific Research Partners, LLC
Oakland, California
Artemis Institute for Clinical Research
San Diego, California
Optimus Medical Group
San Francisco, California
Artemis Institute for Clinical Research
San Marcos, California
Neurological Research Institute
Santa Monica, California
California Neuroscience Research Medical Group
Sherman Oaks, California
Ki Health Partners, LLC, dba New England Institute for Clinical Research
Stamford, Connecticut
Riverside Clinical Research
Edgewater, Florida
Galiz Research
Hialeah, Florida
Multi-Specialty Research Associates, Inc.
Lake City, Florida
Qps Mra, Llc
Miami, Florida
AppleMed Research Group, LLC
Miami, Florida
Harmony Clinical Research
North Miami Beach, Florida
Ormond Medical Arts Pharmaceutical Research Center
Ormond Beach, Florida
JSV Clinical Research Study Inc.
Tampa, Florida
Premiere Research Institute
West Palm Beach, Florida
iResearch Atlanta, LLC
Decatur, Georgia
Northwest Clinical Trials, Inc
Boise, Idaho
R&R Clinical Research
Idaho Falls, Idaho
Cedar Crosse Research Center
Chicago, Illinois
Family Medicine Specialists/CIS
Wauconda, Illinois
Community Clinical Research Center
Anderson, Indiana
Heartland Research Associates, LLC
Newton, Kansas
Phoenix Medical Research
Prairie Village, Kansas
Heartland Research Associates, LLC
Wichita, Kansas
Crescent City Headache and Neurology Center
Chalmette, Louisiana
New Orleans Center for Clinical Research
New Orleans, Louisiana
DelRicht Research
New Orleans, Louisiana
Boston Clinical Trials
Boston, Massachusetts
ActivMed Practices & Research, Inc.
Methuen, Massachusetts
Showing 40 of 93 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.